Join us for an informative webinar that will delve into the latest advancements in antibacterial and antimalarial drug discovery. Hear from experts in the field as they share their insights and experiences on navigating the complexities of drug development and leveraging innovative tools to optimize outcomes.

Moderator: Charles Mowbray, Discovery Director, Drugs for Neglected Diseases initiative (DNDi), Switzerland

Presentation 1: Structure Activity Relationship Optimisation – Case Studies
Speaker: Alastair Parkes, Vice-President, Medicinal Chemistry, Evotec, UK

The first presentation will discuss common challenges encountered in antibacterial drug discovery. He will utilize various case studies to demonstrate practical strategies for overcoming these hurdles, providing attendees with tangible, applicable knowledge.

Presentation 2: The Experimental Validation of MAIP: An Open-Source Tool That Can Enrich the Output from HTS and Identify Novel, Druglike Molecules with Antimalarial Activity
Speaker: James Duffy, Senior Director, Drug Discovery, Medicines for Malaria Venture (MMV), UK

The second presentation will spotlight the development and application of the MAlaria Inhibitor Prediction (MAIP) web platform. A collaboration between pharmaceutical companies and not-for-profit organisations, this open-access tool hosted by the European Bioinformatics Institute (EMBL-EBI) is freely available for researchers worldwide.